[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].
Identifieur interne : 000109 ( Main/Exploration ); précédent : 000108; suivant : 000110[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].
Auteurs : Y D Peng [République populaire de Chine] ; K. Meng [République populaire de Chine] ; H Q Guan [République populaire de Chine] ; L. Leng [République populaire de Chine] ; R R Zhu [République populaire de Chine] ; B Y Wang [République populaire de Chine] ; M A He [République populaire de Chine] ; L X Cheng [République populaire de Chine] ; K. Huang [République populaire de Chine] ; Q T Zeng [République populaire de Chine]Source :
- Zhonghua xin xue guan bing za zhi [ 0253-3758 ] ; 2020.
Abstract
Objective: To explore the clinical characteristics and prognosis of the new coronavirus 2019-nCoV patients combined with cardiovascular disease (CVD). Methods: A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. Results: Compared with the general group, the lymphocyte count (0.74×10(9) (0.34×10(9), 0.94×10(9))/L vs. 0.99×10(9) (0.71×10(9), 1.29×10(9))/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) μg/L vs. 0.11 (0.06,0.20)μg/L, P<0.001) were significantly higher in the critical group. The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m(2) vs. 22.0 (20.0, 24.0) kg/m(2), P=0.003). Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%). Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m(2), which was significantly higher than that of survivors (18.95% (18/95), P<0.001). Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors. There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors (all P>0.05). Conclusion: COVID-19 patients combined with CVD are associated with a higher risk of mortality. Critical patients are characterized with lower lymphocyte counts. Higher BMI are more often seen in critical patients and non-survivor. ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD. Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events.
DOI: 10.3760/cma.j.cn112148-20200220-00105
PubMed: 32120458
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000896
- to stream PubMed, to step Curation: 000896
- to stream PubMed, to step Checkpoint: 000104
- to stream Ncbi, to step Merge: 000C77
- to stream Ncbi, to step Curation: 000C77
- to stream Ncbi, to step Checkpoint: 000C77
- to stream Main, to step Merge: 000111
- to stream Main, to step Curation: 000109
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].</title>
<author><name sortKey="Peng, Y D" sort="Peng, Y D" uniqKey="Peng Y" first="Y D" last="Peng">Y D Peng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meng, K" sort="Meng, K" uniqKey="Meng K" first="K" last="Meng">K. Meng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guan, H Q" sort="Guan, H Q" uniqKey="Guan H" first="H Q" last="Guan">H Q Guan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leng, L" sort="Leng, L" uniqKey="Leng L" first="L" last="Leng">L. Leng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhu, R R" sort="Zhu, R R" uniqKey="Zhu R" first="R R" last="Zhu">R R Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, B Y" sort="Wang, B Y" uniqKey="Wang B" first="B Y" last="Wang">B Y Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="He, M A" sort="He, M A" uniqKey="He M" first="M A" last="He">M A He</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cheng, L X" sort="Cheng, L X" uniqKey="Cheng L" first="L X" last="Cheng">L X Cheng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, K" sort="Huang, K" uniqKey="Huang K" first="K" last="Huang">K. Huang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zeng, Q T" sort="Zeng, Q T" uniqKey="Zeng Q" first="Q T" last="Zeng">Q T Zeng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32120458</idno>
<idno type="pmid">32120458</idno>
<idno type="doi">10.3760/cma.j.cn112148-20200220-00105</idno>
<idno type="wicri:Area/PubMed/Corpus">000896</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000896</idno>
<idno type="wicri:Area/PubMed/Curation">000896</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000896</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000104</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000104</idno>
<idno type="wicri:Area/Ncbi/Merge">000C77</idno>
<idno type="wicri:Area/Ncbi/Curation">000C77</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C77</idno>
<idno type="wicri:doubleKey">0253-3758:2020:Peng Y:clinical:characteristics:and</idno>
<idno type="wicri:Area/Main/Merge">000111</idno>
<idno type="wicri:Area/Main/Curation">000109</idno>
<idno type="wicri:Area/Main/Exploration">000109</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].</title>
<author><name sortKey="Peng, Y D" sort="Peng, Y D" uniqKey="Peng Y" first="Y D" last="Peng">Y D Peng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meng, K" sort="Meng, K" uniqKey="Meng K" first="K" last="Meng">K. Meng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guan, H Q" sort="Guan, H Q" uniqKey="Guan H" first="H Q" last="Guan">H Q Guan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leng, L" sort="Leng, L" uniqKey="Leng L" first="L" last="Leng">L. Leng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhu, R R" sort="Zhu, R R" uniqKey="Zhu R" first="R R" last="Zhu">R R Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wang, B Y" sort="Wang, B Y" uniqKey="Wang B" first="B Y" last="Wang">B Y Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="He, M A" sort="He, M A" uniqKey="He M" first="M A" last="He">M A He</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cheng, L X" sort="Cheng, L X" uniqKey="Cheng L" first="L X" last="Cheng">L X Cheng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, K" sort="Huang, K" uniqKey="Huang K" first="K" last="Huang">K. Huang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zeng, Q T" sort="Zeng, Q T" uniqKey="Zeng Q" first="Q T" last="Zeng">Q T Zeng</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022</wicri:regionArea>
<placeName><settlement type="city">Wuhan</settlement>
<region type="région">Hubei</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Zhonghua xin xue guan bing za zhi</title>
<idno type="ISSN">0253-3758</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><b>Objective:</b>
To explore the clinical characteristics and prognosis of the new coronavirus 2019-nCoV patients combined with cardiovascular disease (CVD). <b>Methods:</b>
A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. They were divided into critical group (ICU, <i>n</i>
=16) and general group (<i>n</i>
=96) according to the severity of the disease and patients were followed up to the clinical endpoint. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. <b>Results:</b>
Compared with the general group, the lymphocyte count (0.74×10(9) (0.34×10(9), 0.94×10(9))/L vs. 0.99×10(9) (0.71×10(9), 1.29×10(9))/L, <i>P</i>
=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, <i>P</i>
<0.001) and PCT (0.20 (0.15,0.48) μg/L vs. 0.11 (0.06,0.20)μg/L, <i>P</i>
<0.001) were significantly higher in the critical group. The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m(2) vs. 22.0 (20.0, 24.0) kg/m(2), <i>P</i>
=0.003). Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%). Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m(2), which was significantly higher than that of survivors (18.95% (18/95), <i>P</i>
<0.001). Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), <i>P</i>
<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, <i>P</i>
<0.001) was significantly higher in the non-survivors. There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors (all <i>P</i>
>0.05). <b>Conclusion:</b>
COVID-19 patients combined with CVD are associated with a higher risk of mortality. Critical patients are characterized with lower lymphocyte counts. Higher BMI are more often seen in critical patients and non-survivor. ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD. Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<region><li>Hubei</li>
</region>
<settlement><li>Wuhan</li>
</settlement>
</list>
<tree><country name="République populaire de Chine"><region name="Hubei"><name sortKey="Peng, Y D" sort="Peng, Y D" uniqKey="Peng Y" first="Y D" last="Peng">Y D Peng</name>
</region>
<name sortKey="Cheng, L X" sort="Cheng, L X" uniqKey="Cheng L" first="L X" last="Cheng">L X Cheng</name>
<name sortKey="Guan, H Q" sort="Guan, H Q" uniqKey="Guan H" first="H Q" last="Guan">H Q Guan</name>
<name sortKey="He, M A" sort="He, M A" uniqKey="He M" first="M A" last="He">M A He</name>
<name sortKey="Huang, K" sort="Huang, K" uniqKey="Huang K" first="K" last="Huang">K. Huang</name>
<name sortKey="Leng, L" sort="Leng, L" uniqKey="Leng L" first="L" last="Leng">L. Leng</name>
<name sortKey="Meng, K" sort="Meng, K" uniqKey="Meng K" first="K" last="Meng">K. Meng</name>
<name sortKey="Wang, B Y" sort="Wang, B Y" uniqKey="Wang B" first="B Y" last="Wang">B Y Wang</name>
<name sortKey="Zeng, Q T" sort="Zeng, Q T" uniqKey="Zeng Q" first="Q T" last="Zeng">Q T Zeng</name>
<name sortKey="Zhu, R R" sort="Zhu, R R" uniqKey="Zhu R" first="R R" last="Zhu">R R Zhu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000109 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000109 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32120458 |texte= [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32120458" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |